Stocks in Play

Helix BioPharma Corp.

03:26 PM EST - Helix BioPharma Corp. : Has signed a non-binding letter of intent with ProMab Biotechnologies to develop cell based therapies. Helix BioPharma Corp. shares T.HBP are trading unchanged at $1.40.